Ivabradine: Difference between revisions
From IDWiki
(Created page with "== Dosing == * Heart failure ** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >60 bpm after 2 weeks ** Decreases readmission but no mortality benef...") |
No edit summary |
||
| Line 4: | Line 4: | ||
** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >60 bpm after 2 weeks |
** Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >60 bpm after 2 weeks |
||
** Decreases readmission but no mortality benefit |
** Decreases readmission but no mortality benefit |
||
== Adverse Effects == |
|||
* Generally well-tolerated |
|||
* May have visual effects (flashing lights) |
|||
* Monitor QTc |
|||
[[Category:Medications]] |
[[Category:Medications]] |
||
Revision as of 18:04, 14 October 2021
Dosing
- Heart failure
- Start at 5 mg PO bid and increase to 7.5 mg PO bid if sinus rhythm still >60 bpm after 2 weeks
- Decreases readmission but no mortality benefit
Adverse Effects
- Generally well-tolerated
- May have visual effects (flashing lights)
- Monitor QTc
